Cargando…
Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice
BACKGROUND: Non-alcoholic liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome, and it can progress to non-alcoholic steatohepatitis (NASH). Alterations in the gut microbiome have been implicated in the development of NAFLD/NASH, although the underlying mechanisms remain unclear....
Autores principales: | Aoki, Ryo, Onuki, Masayoshi, Hattori, Koya, Ito, Masato, Yamada, Takahiro, Kamikado, Kohei, Kim, Yun-Gi, Nakamoto, Nobuhiro, Kimura, Ikuo, Clarke, Julie M., Kanai, Takanori, Hase, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447789/ https://www.ncbi.nlm.nih.gov/pubmed/34530928 http://dx.doi.org/10.1186/s40168-021-01125-7 |
Ejemplares similares
-
The Commensal Microbe V
eillonella as a Marker for Response to an FGF19 Analog in NASH
por: Loomba, Rohit, et al.
Publicado: (2020) -
Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017) -
The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018) -
Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020) -
Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)